MEST and osteosarcoma: MEST and CXCL5 were also shown to be under-expressed in 29/29 osteosarcoma clinical samples, respectively, whereas NNAT was under-expressed in 27/29 samples, based on identical types of microarray data (no methylation data was available) [27].